Cannabis Suisse Corp. (CSUI) EBIT (2016 - 2026)

Cannabis Suisse (CSUI) has reported EBIT for 11 consecutive years, with -$69394.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, EBIT fell 3.9% year-over-year to -$69394.0 in Q1 2026; TTM through Feb 2026 was -$282986.0, a 10.64% increase from a year earlier, with the FY2025 full-year figure at -$288013.0, down 12.09% from the prior year.
• EBIT was -$69394.0 for Q1 2026 at Cannabis Suisse, up from -$74980.0 in the prior quarter.
• Over five years, EBIT peaked at -$22766.0 in Q2 2022 and troughed at -$156052.0 in Q1 2023.
• A 5-year average of -$69437.1 and a median of -$66788.0 in 2025 frame the typical range for EBIT.
• Across the five-year window, EBIT soared 96.63% in 2022 and plunged 279.47% in 2023, its largest moves.
• Over 5 years, EBIT stood at -$29375.0 in 2022, then slumped by 72.6% to -$50702.0 in 2023, then slumped by 82.06% to -$92309.0 in 2024, then rose by 18.77% to -$74980.0 in 2025, then advanced by 7.45% to -$69394.0 in 2026.
• The last three EBIT figures came in at -$69394.0 (Q1 2026), -$74980.0 (Q4 2025), and -$84535.0 (Q3 2025), per Business Quant data.